Humans and AI will soon crack de novo antibody design
Our Observations
- AI companies either scale with compute or don't scale at all
- Proteins are dynamic structures, but existing data is biased toward static structures
- ML objectives must explicitly optimize diversity else models fail to generalize outside the narrow slice of measured antibody space
Partnership
We are currently developing AI-designed VHH antibody libraries for CRO partners to enhance hit discovery and maturation for difficult targets. Email us - [email protected].